IL6 and metabolic dysfunction-associated steatotic liver disease: Our findings suggest that measuring P1NP, IL-6 or M2BPGi along with the basic chemistry tests would help determine the stage of NAFLD they correspond to at the time of initial diagnosis and predict responsiveness after the treatment.